References
[1] January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE,
Cleveland JC, et al. 2014 AHA/ACC/HRS Guideline for the Management of
Patients With Atrial Fibrillation: A Report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
and the Heart Rhythm Society. 2014.
[2] Morillo, Carlos, A, et al. Radiofrequency Ablation vs
Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial
Fibrillation (RAAFT-2).[J]. JAMA: Journal of the American Medical
Association, 2014, 311(7):692-699. [3] Kagawa Y, Fujii E, Fujita S,
Ito M. Association between left atrial reverse remodeling and
maintenance of sinus rhythm after catheter ablation of persistent atrial
fibrillation. Heart Vessels. 2020;35:239-45.
[4] Chew D, Piccini JP. Long-term oral anticoagulant after catheter
ablation for atrial fibrillation. Europace. 2021.
[5] Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et
al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter
Ablation for Human Atrial Fibrillation. 2005;111:1100-5.
[6] 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and
Surgical Ablation of Atrial Fibrillation: Recommendations for Patient
Selection, Procedural Techniques, Patient Management and Follow-up,
Definitions, Endpoints, and Research Trial Design %J Heart Rhythm.
2012;9:632-96.
[7] Jianhui Z, Yi W, Kai T, Xiankai L, Wenhui P, Chun L, et al.
Association between left atrial size and atrial fibrillation recurrence
after single circumferential pulmonary vein isolation: a systematic
review and meta-analysis of observational studies. 2012:638-45.
[8] Clementy N, Benhenda N, Piver E, Pierre B, Bernard A, Fauchier
L, et al. Serum Galectin-3 Levels Predict Recurrences after Ablation of
Atrial Fibrillation. 2016;6:34357.
[9] Wu G, Wang S, Cheng M, Peng B, Liang J, Huang H, et al. The
serum matrix metalloproteinase-9 level is an independent predictor of
recurrence after ablation of persistent atrial fibrillation.
2016;71:251-6.
[10] Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T,
Nishiyama N, et al. Serum Inflammation Markers Predicting Successful
Initial Catheter Ablation for Atrial Fibrillation. 2014;23:636-43.
[11] Dal-Bianco JP, Levine RA. Anatomy of the mitral valve
apparatus: role of 2D and 3D echocardiography. Cardiol Clin.
2013;31:151-64.
[12] Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E,
Grayburn PA, et al. Recommendations for Noninvasive Evaluation of Native
Valvular Regurgitation: A Report from the American Society of
Echocardiography Developed in Collaboration with the Society for
Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr.
2017;30:303-71.
[13] A WAZ, Fase Chair, B DAR, Rdcs, Fase, C ROB, D ES, Elyse Foster
FE, F PAG, Fase, et al. Recommendations for Noninvasive Evaluation of
Native Valvular Regurgitation. 2017;30:303-71.
[14] A J, Hanley, J B, Radiology MJ. The meaning and use of the area
under a receiver operating characteristic (ROC) curve. 1982.
[15] Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F,
Natale A,et al.Comparison of antiarrhythmic drug therapy and
radiofrequency catheter ablation in patients with paroxysmal atrial
fibrillation : A randomized controlled trial. 2010;303:333-40.
[16] Santangeli P, Di Biase L, Natale AJCA, Electrophysiology.
Ablation Versus Drugs: What Is the Best First-Line Therapy for
Paroxysmal Atrial Fibrillation?: Antiarrhythmic Drugs Are Outmoded and
Catheter Ablation Should Be the First-Line Option for All Patients With
Paroxysmal Atrial Fibrillation: Pro. 2014;7:739-46.
[17] Mesquita J, Ferreira AM, Cavaco D, Moscoso Costa F, Carmo P,
Marques H, et al. Development and validation of a risk score for
predicting atrial fibrillation recurrence after a first catheter
ablation procedure - ATLAS score. Europace. 2018;20:f428-f35.
[18] Kornej J, Hindricks G, Shoemaker MB, Husser D, Arya A, Sommer
P, et al. The APPLE score: a novel and simple score for the prediction
of rhythm outcomes after catheter ablation of atrial fibrillation. Clin
Res Cardiol. 2015;104:871-6.
[19] Winkle RA, Jarman JW, Mead RH, Engel G, Kong MH, Fleming W, et
al. Predicting atrial fibrillation ablation outcome: The CAAP-AF score.
Heart Rhythm. 2016;13:2119-25.
[20] Jiang H, Wang W, Wang C, Xie X, Hou Y. Association of
pre-ablation level of potential blood markers with atrial fibrillation
recurrence after catheter ablation: a meta-analysis. Europace.
2017;19:392-400.
[21] Wynn GJ, Das M, Bonnett LJ, Gupta D. Quality-of-life benefits
of catheter ablation of persistent atrial fibrillation: a reanalysis of
data from the SARA study. Europace. 2015;17:222-4.
[22] Cristina F, Marina A, Simone F, Cristina G, Walter GM, Mara M,
et al. Prediction of atrial fibrillation recurrence after cardioversion
in patients with left-atrial dilation. 2015:335-41.
[23] David D, Michelson EL, Naito M, Chen CC, Schaffenburg M,
Dreifus LS. Diastolic ”locking” of the mitral valve: the importance of
atrial systole and intraventricular volume. Circulation. 1983;67:640-5.
[24] Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski
FE, et al. Evidence of atrial functional mitral regurgitation due to
atrial fibrillation: reversal with arrhythmia control. J Am Coll
Cardiol. 2011;58:1474-81.
[25] Gertz ZM, Raina A, Mountantonakis SE, Zado ES, Callans DJ,
Marchlinski FE, Keane MG, Silvestry FE. The impact of mitral
regurgitation on patients undergoing catheter ablation of atrial
fibrillation. Europace. 2011; 13:1127-1132..
[26] Rosendael PJV, Katsanos S, Kamperidis V, Roos CJ, Scholte AJHA,
Schalij MJ, et al. New Insights on Carpentier I Mitral Regurgitation
from Multidetector Row Computed Tomography - ScienceDirect.
2014;114:763-8.
[27] Mitral Regurgitation Associated with Mitral Annular Dilation in
Patients with Lone Atrial Fibrillation: An Echocardiographic Study.
2009;26:885-9.
[28] L Z, W J, L Z, J G, Y W, Y L, et al. The role of valvular
regurgitation in catheter ablation outcomes of patients with
long-standing persistent atrial fibrillation. 2014;16:848-54.
[29] Qiao Y, Wu L, Hou B, Sun W, Yao YJM. Functional mitral
regurgitation: predictor for atrial substrate remodeling and poor
ablation outcome in paroxysmal atrial fibrillation. Medicine
(Baltimore). 2016;95:e4333.
[30] Otsuji Y, Kumanohoso T, Yoshifuku S, Matsukida K, Koriyama C,
Kisanuki A, et al. Isolated annular dilation does not usually cause
important functional mitral regurgitation: comparison between patients
with lone atrial fibrillation and those with idiopathic or ischemic
cardiomyopathy. J Am Coll Cardiol. 2002;39:1651-6.
[31] Silbiger JJ. Echocardiographic examination of the posterior
atrioventricular groove. Echocardiography. 2014;31:223-33.
[32] Silbiger JJ. Mechanistic insights into atrial functional mitral
regurgitation: Far more complicated than just left atrial remodeling.
Echocardiography. 2019;36:164-9.
[33] Wunderlich NC, Beigel R, Swaans MJ, Ho SY, Siegel RJ.
Percutaneous interventions for left atrial appendage exclusion: options,
assessment, and imaging using 2D and 3D echocardiography. JACC
Cardiovasc Imaging. 2015;8:472-88.
[34] Melduni RM, Malouf JF, Chandrasekaran K, Bruce CJ, White RD,
Law KK, et al. New insights into the predictors of left atrial stunning
after successful direct-current cardioversion of atrial fibrillation and
flutter. J Am Soc Echocardiogr. 2008;21:848-54.
[35] Melduni RM, Lee HC, Bailey KR, Miller FA, Jr., Hodge DO, Seward
JB, et al. Real-time physiologic biomarker for prediction of atrial
fibrillation recurrence, stroke, and mortality after electrical
cardioversion: A prospective observational study. Am Heart J.
2015;170:914-22.
[36] Pálinkás A, Antonielli E, Picano E, Pizzuti A, Varga A, Nyúzó
B, et al. Clinical value of left atrial appendage flow velocity for
predicting of cardioversion success in patients with non-valvular atrial
fibrillation. Eur Heart J. 2001;22:2201-8.
[37] He Y, Zhang B, Zhu F, Hu Z, Zhong J, Zhu W. Transesophageal
echocardiography measures left atrial appendage volume and function and
predicts recurrence of paroxysmal atrial fibrillation after
radiofrequency catheter ablation. Echocardiography. 2018;35:985-90.
[38] Yang Z, Xu M, Zhang C, Liu H, Shao X, Wang Y, et al. A
predictive model using left atrial function and B-type natriuretic
peptide level in predicting the recurrence of early persistent atrial
fibrillation after radiofrequency ablation. Clin Cardiol.
2021;44:407-14.